Azurity Pharmaceuticals 召回了一批 Zenzedi，因为包装上贴错标签，其中含有抗组胺药而不是多动症药物。 Azurity Pharmaceuticals recalls one Zenzedi lot due to mislabeled package containing antihistamines instead of ADHD medication.
由于包装标签错误，Azurity Pharmaceuticals 召回了一批多动症药物 Zenzedi。 Azurity Pharmaceuticals has recalled one lot of its ADHD medication, Zenzedi, due to a mislabeled package. 错误包装中含有马来酸卡比沙明片剂（一种抗组胺药物），而不是 Zenzedi CII（硫酸右旋苯丙胺片剂，USP）30 毫克。 The incorrect package contained Carbinoxamine Maleate tablets, an antihistamine drug, instead of Zenzedi CII (dextroamphetamine sulfate tablets, USP) 30 milligrams. 受影响批次于2023年8月23日至11月29日期间运往批发商。 The affected lot was shipped to wholesalers between August 23 and November 29, 2023. 内布拉斯加州的一名药剂师报告在一瓶 Zenzedi 中发现了错误的药片后，该公司展开了调查。 The company launched an investigation after a pharmacist in Nebraska reported finding the wrong tablets in a bottle of Zenzedi.